|
- 2017
双醋瑞因对2型糖尿病大鼠炎性因子和脂代谢的影响及脂肪组织chemerin的表达变化
|
Abstract:
摘要:目的 探讨双醋瑞因及其代谢产物大黄酸对2型糖尿病(T2DM)大鼠血清炎症因子和肾周脂肪组织chemerin蛋白表达水平的影响及调节糖脂代谢的作用。方法 56只雄性SD大鼠随机分组,正常对照组(A组)予普通饲料,其余各组予高脂饲料喂养;第8周末,经腹腔注射链脲佐菌素(STZ)溶液造模(A组予注射同等体积无菌柠檬酸钠溶液),于第10周末根据OGTT实验结果筛选成模大鼠,分别分为T2DM组(B组)、吡格列酮组(C组)、双醋瑞因组(D组)、吡格列酮+双醋瑞因组(E组),干预4周。实验第10、14周末禁食不禁水取血并检测血糖、血脂、空腹胰岛素(FINS)、白介素-1β(IL-1β)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)。第14周末心脏取血后,处死所有大鼠并分离大鼠肾周脂肪组织,Western blotting检测肾周脂肪组织chemerin表达。结果 第10周末,B、C、D、E组的空腹血糖(FBG)、FINS、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、IL-1β、IL-6、TNF-α均高于A组(P<0.01),高密度脂蛋白胆固醇(HDL-C)低于A组(P<0.01)。第14周末,C、D、E组FBG、FINS、TC、TG、LDL-C、IL-1β、IL-6、TNF-α均低于B组而高于A组(P<0.05),而HDL-C低于A组(P<0.05)。E组糖脂代谢及炎症因子水平变化大于C、D组(P<0.05)。Western blotting结果显示,B组chemerin表达增高,高于其他组(P<0.05),而C、D组chemerin表达高于A、E组(P<0.05),A组与E组差异无统计学意义。结论 双醋瑞因可能通过影响糖尿病大鼠chemerin及相关炎症细胞因子表达,调节血脂代谢,改善胰岛素抵抗,遏制T2DM发展。
ABSTRACT: Objective To study the effects of diacerein and its metabolite rhein on plasma inflammatory cytokine level and expression of perirenal adipose tissue chemerin in type 2 diabetes mellitus (T2DM) rats and its role in regulating glucose and lipid metabolism. Methods We randomly divided 56 SD male rats into 5 groups: normal control group (Group A), T2DM group (Group B), pioglitazone group (Group C), diacerein group (Group D), and pioglitazone+diacerein group (Group E). Group A was fed with ordinary feed whereas the other groups were fed with high-fat diet. At the end of week 8, rats in Groups B, C, D and E were injected intraperitoneally with 30mg/kg of STZ solution to create the model. Those in Group A were injected with the same volume of sterile sodium citrate solution. OGTT examination was taken to screen the model rats at the end of week 10. The successful mode was chosen according to OGTT result. Then Group C was treated with pioglitazone 10mg/(kg?d) orally, Group D with diacerein 50mg/(kg?d), Group E with pioglitazone 10mg/(kg?d)+diacerein 50mg/(kg?d), and Group A and B were given the same volume of normal saline. The intervention lasted 4 weeks. At the end of experiment weeks 10 and 14, FBG, FINS, TC, TG, LDL-C, IL-1β, IL-6, and TNF-α were detected in the fasting rats with free access to water. After blood sample was taken at the end of week 14, all rats were killed and the perirenal adipose tissue was isolated, the expression of chemerin in perirenal adipose tissue was detected by Western blotting. Results At the end of week 10, FBG, FINS, TG, TC, LDL-C, IL-1β, IL-6, and TNF-α were higher in Groups B, C, D and E than in Group A while HDL-C was lower (all P<0.01). At the end of week 14, TC, TG, and LDL-C were lower in Groups C, D and E
[1] | LEHRKE M, BECKER A, GREIF M, et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis[J]. Eur J Endocrinol, 2009, 161(2):339-344. |
[2] | AGRAWAL NK, KANT S. Targeting inflammation in diabetes: Newer therapeutic options[J]. World J Diabetes, 2014, 5(5):697-710. |
[3] | 李冰,冯凭. 罗格列酮干预糖尿病大鼠脂肪组织CMKLR1及Chemerin基因表达[J]. 天津医科大学学报, 2015, 21(6):484-487. |
[4] | NISHIMURA S, MANABE I, NAGASAKI M, et al. In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue[J]. J Clin Invest, 2008, 118(2):710-721. |
[5] | MASTERS SL, DUNNE A, SUBRAMANIAN SL, et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes[J]. Nat Immunol, 2010, 11(10):897-904. |
[6] | ROMAN AA, PARLEE SD, SINAL CJ. Chemerin: A potential endocrine link between obesity and type 2 diabetes[J]. Endocrine, 2012, 42(2):243-251. |
[7] | 张学亮,郭啸华,刘志红,等. 大黄酸对低剂量链脲佐菌素肥胖糖尿病大鼠糖尿病肾病的影响[J]. 中华内分泌代谢杂志, 2005, 21(6):563-565. |
[8] | CAI K, QI D, WANG O, et al. TNF-alpha acutely upregulates amylin expression in murine pancreatic beta cells[J]. Diabetologia, 2011, 54(3):617-626. |
[9] | KOENEN TB, STIENSTRA R, VAN TITS LJ, et al. Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue[J]. Diabetes, 2011, 60(2):517-524. |
[10] | GRANT RW, DIXIT VD. Mechanisms of disease: Inflammasome activation and the development of type 2 diabetes[J]. Front Immunol, 2013, 4:50. |
[11] | LUKIC L, LALIC NM, RAJKOVIC N, et al. Hypertension in obese type 2 diabetes patients is associated with increases in insulin resistance and IL-6 cytokine levels: Potential targets for an efficient preventive intervention[J]. Int J Environ Res Public Health, 2014,11(4):3586-3598. |
[12] | DOU L, ZHAO T, WANG L, et al. miR-200s contribute to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes[J]. J Biol Chem, 2013, 288(31):22596-22606. |
[13] | 杨波,杨孟雪,高琳,等. 血清Chemerin水平与2型糖尿病合并大血管病变及腰身比的相关性研究[J]. 中国糖尿病杂志, 2016, 24(4):304-308. |
[14] | LI Y, SHI B, LI S. Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: A meta-analysis[J]. PLoS One, 2014, 9(12):e113915. |
[15] | RAMOS-ZAVALA MG, GONZALEZ-ORTIZ M, MARTINEZ-ABUNDIS E, et al. Effect of diacerein on insulin secretion and metabolic control in drug-naive patients with type 2 diabetes: A randomized clinical trial[J]. Diabetes Care, 2011, 34(7):1591-1594. |